Indication
Hepatitis Delta Virus Infection
1 clinical trial
3 products
Product
HH-003(20mg/kg)Product
HH-003(10mg/kg)Clinical trial
A Multicenter, Randomized, Controlled, Open-label Phase IIb Study to Assess Efficacy and Safety of HH-003 Injection in Subjects With Chronic Hepatitis Delta Virus InfectionStatus: Recruiting, Estimated PCD: 2024-06-30
Product
TAF